Most preferred immune response-enhancing agents useful herein are those compounds in which R4 are the 1'-beta-D-ribofuranosidyl and 1'-beta-D-2'-deoxyribofuranosidyl radicals, in which R1, R2 and R3 are particularly preferred, X is oxygen, and Z is N-R2, as discussed before.